膿痂疹治療薬の世界市場インサイト、2029年までの予測Global Impetigo Medicines Market Insights, Forecast to 2029 世界の膿痂疹治療薬市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ドルに比べ、2023年には100万米ドルに達すると予想されている。川下産業からの需要増加を背景に、膿痂疹治療薬... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー世界の膿痂疹治療薬市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ドルに比べ、2023年には100万米ドルに達すると予想されている。川下産業からの需要増加を背景に、膿痂疹治療薬産業は2029年に百万米ドルに達すると評価されている。2023年から2029年までのCAGRは%である。世界の医薬品市場は、2022年に1475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの対象 本レポートは、2018年から2029年までの世界の膿痂疹治療薬市場の概要を紹介し、読者が世界の膿痂疹治療薬市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域別の売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高と収益も強調しています。 レポートに掲載されているメーカー、タイプ、アプリケーション、地域 企業別 Cutanea Life Sciences レオファーマ メディメトリックス・ファーマシューティカルズ グラクソ・スミスクライン ファイザー カラレックス・ファーマ ノバベイ・ファーマシューティカルズ ロシュ・ホールディングAG サンドスGmbH タロ・ファーマシューティカル・インダストリーズ テバ・ファーマシューティカル・インダストリーズ タイプ別セグメント 漢方薬 西洋薬 用途別セグメント 病院 薬局 地域別セグメント 米国・カナダ 米国 カナダ 中国 アジア(中国を除く) 日本 韓国 中国 台湾 東南アジア インド ヨーロッパ ドイツ フランス 英国 イタリア ロシア ラテンアメリカ、中東、アフリカ ブラジル メキシコ トルコ イスラエル GCC諸国 章の概要 第1章:製品の定義、種類、用途の紹介 第2章:2018年から2029年までの地域別収益および販売量分析 第3章:メーカーの膿痂疹治療薬の工場分布、膿痂疹治療薬の市販日、提供される製品タイプ、M&A、拡大活動を含むメーカーの売上、収益、価格分析 第4章:2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析 第5章:2018年から2029年までの世界的な用途別製品売上高、収益および価格分析 第6章:米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国&カナダにおける各国別製品売上高、収益分析 第7章:ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析 第8章:2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析 第9章:2018年から2029年までのアジア(中国を除く)における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア(中国を除く)各国の製品売上高、収益分析 第10章:2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。 第11章:メーカーの概要、企業の基本情報、主要事業、膿痂疹治療薬の紹介など。2018年から2023年までの各社の膿痂疹治療薬の売上高、収益、価格、およびグロスマージン 第12章:原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析 第13章:市場機会と課題分析 第14章:膿痂疹治療薬に関するQYResearchの結論 第15章:QYResearchが採用した方法論とデータソース 目次1 Study Coverage1.1 Impetigo Medicines Product Introduction 1.2 Market by Type 1.2.1 Global Impetigo Medicines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Traditional Chinese Medicine 1.2.3 Western Medicine 1.3 Market by Application 1.3.1 Global Impetigo Medicines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029 2.2 Global Impetigo Medicines Revenue by Region 2.2.1 Global Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Impetigo Medicines Revenue by Region (2018-2023) 2.2.3 Global Impetigo Medicines Revenue by Region (2024-2029) 2.2.4 Global Impetigo Medicines Revenue Market Share by Region (2018-2029) 2.3 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029 2.4 Global Impetigo Medicines Sales by Region 2.4.1 Global Impetigo Medicines Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Impetigo Medicines Sales by Region (2018-2023) 2.4.3 Global Impetigo Medicines Sales by Region (2024-2029) 2.4.4 Global Impetigo Medicines Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Impetigo Medicines Sales by Manufacturers 3.1.1 Global Impetigo Medicines Sales by Manufacturers (2018-2023) 3.1.2 Global Impetigo Medicines Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Impetigo Medicines in 2022 3.2 Global Impetigo Medicines Revenue by Manufacturers 3.2.1 Global Impetigo Medicines Revenue by Manufacturers (2018-2023) 3.2.2 Global Impetigo Medicines Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Impetigo Medicines Revenue in 2022 3.3 Global Key Players of Impetigo Medicines, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Impetigo Medicines Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Impetigo Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Impetigo Medicines, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Impetigo Medicines, Product Offered and Application 3.8 Global Key Manufacturers of Impetigo Medicines, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Impetigo Medicines Sales by Type 4.1.1 Global Impetigo Medicines Historical Sales by Type (2018-2023) 4.1.2 Global Impetigo Medicines Forecasted Sales by Type (2024-2029) 4.1.3 Global Impetigo Medicines Sales Market Share by Type (2018-2029) 4.2 Global Impetigo Medicines Revenue by Type 4.2.1 Global Impetigo Medicines Historical Revenue by Type (2018-2023) 4.2.2 Global Impetigo Medicines Forecasted Revenue by Type (2024-2029) 4.2.3 Global Impetigo Medicines Revenue Market Share by Type (2018-2029) 4.3 Global Impetigo Medicines Price by Type 4.3.1 Global Impetigo Medicines Price by Type (2018-2023) 4.3.2 Global Impetigo Medicines Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Impetigo Medicines Sales by Application 5.1.1 Global Impetigo Medicines Historical Sales by Application (2018-2023) 5.1.2 Global Impetigo Medicines Forecasted Sales by Application (2024-2029) 5.1.3 Global Impetigo Medicines Sales Market Share by Application (2018-2029) 5.2 Global Impetigo Medicines Revenue by Application 5.2.1 Global Impetigo Medicines Historical Revenue by Application (2018-2023) 5.2.2 Global Impetigo Medicines Forecasted Revenue by Application (2024-2029) 5.2.3 Global Impetigo Medicines Revenue Market Share by Application (2018-2029) 5.3 Global Impetigo Medicines Price by Application 5.3.1 Global Impetigo Medicines Price by Application (2018-2023) 5.3.2 Global Impetigo Medicines Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Impetigo Medicines Market Size by Type 6.1.1 US & Canada Impetigo Medicines Sales by Type (2018-2029) 6.1.2 US & Canada Impetigo Medicines Revenue by Type (2018-2029) 6.2 US & Canada Impetigo Medicines Market Size by Application 6.2.1 US & Canada Impetigo Medicines Sales by Application (2018-2029) 6.2.2 US & Canada Impetigo Medicines Revenue by Application (2018-2029) 6.3 US & Canada Impetigo Medicines Market Size by Country 6.3.1 US & Canada Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Impetigo Medicines Sales by Country (2018-2029) 6.3.3 US & Canada Impetigo Medicines Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Impetigo Medicines Market Size by Type 7.1.1 Europe Impetigo Medicines Sales by Type (2018-2029) 7.1.2 Europe Impetigo Medicines Revenue by Type (2018-2029) 7.2 Europe Impetigo Medicines Market Size by Application 7.2.1 Europe Impetigo Medicines Sales by Application (2018-2029) 7.2.2 Europe Impetigo Medicines Revenue by Application (2018-2029) 7.3 Europe Impetigo Medicines Market Size by Country 7.3.1 Europe Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Impetigo Medicines Sales by Country (2018-2029) 7.3.3 Europe Impetigo Medicines Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Impetigo Medicines Market Size 8.1.1 China Impetigo Medicines Sales (2018-2029) 8.1.2 China Impetigo Medicines Revenue (2018-2029) 8.2 China Impetigo Medicines Market Size by Application 8.2.1 China Impetigo Medicines Sales by Application (2018-2029) 8.2.2 China Impetigo Medicines Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Impetigo Medicines Market Size by Type 9.1.1 Asia Impetigo Medicines Sales by Type (2018-2029) 9.1.2 Asia Impetigo Medicines Revenue by Type (2018-2029) 9.2 Asia Impetigo Medicines Market Size by Application 9.2.1 Asia Impetigo Medicines Sales by Application (2018-2029) 9.2.2 Asia Impetigo Medicines Revenue by Application (2018-2029) 9.3 Asia Impetigo Medicines Sales by Region 9.3.1 Asia Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Impetigo Medicines Revenue by Region (2018-2029) 9.3.3 Asia Impetigo Medicines Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Impetigo Medicines Market Size by Type 10.1.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Impetigo Medicines Market Size by Application 10.2.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country 10.3.1 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Cutanea Life Sciences 11.1.1 Cutanea Life Sciences Company Information 11.1.2 Cutanea Life Sciences Overview 11.1.3 Cutanea Life Sciences Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 Cutanea Life Sciences Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Cutanea Life Sciences Recent Developments 11.2 LEO Pharma 11.2.1 LEO Pharma Company Information 11.2.2 LEO Pharma Overview 11.2.3 LEO Pharma Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 LEO Pharma Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 LEO Pharma Recent Developments 11.3 Medimetriks Pharmaceuticals 11.3.1 Medimetriks Pharmaceuticals Company Information 11.3.2 Medimetriks Pharmaceuticals Overview 11.3.3 Medimetriks Pharmaceuticals Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Medimetriks Pharmaceuticals Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Medimetriks Pharmaceuticals Recent Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Information 11.4.2 GlaxoSmithKline Overview 11.4.3 GlaxoSmithKline Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 GlaxoSmithKline Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 GlaxoSmithKline Recent Developments 11.5 Pfizer 11.5.1 Pfizer Company Information 11.5.2 Pfizer Overview 11.5.3 Pfizer Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Pfizer Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Pfizer Recent Developments 11.6 Karalex Pharma, LLC 11.6.1 Karalex Pharma, LLC Company Information 11.6.2 Karalex Pharma, LLC Overview 11.6.3 Karalex Pharma, LLC Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.6.4 Karalex Pharma, LLC Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Karalex Pharma, LLC Recent Developments 11.7 NovaBay Pharmaceuticals, Inc. 11.7.1 NovaBay Pharmaceuticals, Inc. Company Information 11.7.2 NovaBay Pharmaceuticals, Inc. Overview 11.7.3 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.7.4 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 NovaBay Pharmaceuticals, Inc. Recent Developments 11.8 Roche Holding AG 11.8.1 Roche Holding AG Company Information 11.8.2 Roche Holding AG Overview 11.8.3 Roche Holding AG Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.8.4 Roche Holding AG Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Roche Holding AG Recent Developments 11.9 SANDOZ GmbH 11.9.1 SANDOZ GmbH Company Information 11.9.2 SANDOZ GmbH Overview 11.9.3 SANDOZ GmbH Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.9.4 SANDOZ GmbH Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 SANDOZ GmbH Recent Developments 11.10 Taro Pharmaceutical Industries Ltd 11.10.1 Taro Pharmaceutical Industries Ltd Company Information 11.10.2 Taro Pharmaceutical Industries Ltd Overview 11.10.3 Taro Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.10.4 Taro Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Taro Pharmaceutical Industries Ltd Recent Developments 11.11 Teva Pharmaceutical Industries Ltd 11.11.1 Teva Pharmaceutical Industries Ltd Company Information 11.11.2 Teva Pharmaceutical Industries Ltd Overview 11.11.3 Teva Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.11.4 Teva Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Teva Pharmaceutical Industries Ltd Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Impetigo Medicines Industry Chain Analysis 12.2 Impetigo Medicines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Impetigo Medicines Production Mode & Process 12.4 Impetigo Medicines Sales and Marketing 12.4.1 Impetigo Medicines Sales Channels 12.4.2 Impetigo Medicines Distributors 12.5 Impetigo Medicines Customers 13 Market Dynamics 13.1 Impetigo Medicines Industry Trends 13.2 Impetigo Medicines Market Drivers 13.3 Impetigo Medicines Market Challenges 13.4 Impetigo Medicines Market Restraints 14 Key Findings in The Global Impetigo Medicines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryGlobal Impetigo Medicines market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Impetigo Medicines industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2023 to 2029. Table of Contents1 Study Coverage1.1 Impetigo Medicines Product Introduction 1.2 Market by Type 1.2.1 Global Impetigo Medicines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Traditional Chinese Medicine 1.2.3 Western Medicine 1.3 Market by Application 1.3.1 Global Impetigo Medicines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029 2.2 Global Impetigo Medicines Revenue by Region 2.2.1 Global Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Impetigo Medicines Revenue by Region (2018-2023) 2.2.3 Global Impetigo Medicines Revenue by Region (2024-2029) 2.2.4 Global Impetigo Medicines Revenue Market Share by Region (2018-2029) 2.3 Global Impetigo Medicines Sales Estimates and Forecasts 2018-2029 2.4 Global Impetigo Medicines Sales by Region 2.4.1 Global Impetigo Medicines Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Impetigo Medicines Sales by Region (2018-2023) 2.4.3 Global Impetigo Medicines Sales by Region (2024-2029) 2.4.4 Global Impetigo Medicines Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Impetigo Medicines Sales by Manufacturers 3.1.1 Global Impetigo Medicines Sales by Manufacturers (2018-2023) 3.1.2 Global Impetigo Medicines Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Impetigo Medicines in 2022 3.2 Global Impetigo Medicines Revenue by Manufacturers 3.2.1 Global Impetigo Medicines Revenue by Manufacturers (2018-2023) 3.2.2 Global Impetigo Medicines Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Impetigo Medicines Revenue in 2022 3.3 Global Key Players of Impetigo Medicines, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Impetigo Medicines Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Impetigo Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Impetigo Medicines, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Impetigo Medicines, Product Offered and Application 3.8 Global Key Manufacturers of Impetigo Medicines, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Impetigo Medicines Sales by Type 4.1.1 Global Impetigo Medicines Historical Sales by Type (2018-2023) 4.1.2 Global Impetigo Medicines Forecasted Sales by Type (2024-2029) 4.1.3 Global Impetigo Medicines Sales Market Share by Type (2018-2029) 4.2 Global Impetigo Medicines Revenue by Type 4.2.1 Global Impetigo Medicines Historical Revenue by Type (2018-2023) 4.2.2 Global Impetigo Medicines Forecasted Revenue by Type (2024-2029) 4.2.3 Global Impetigo Medicines Revenue Market Share by Type (2018-2029) 4.3 Global Impetigo Medicines Price by Type 4.3.1 Global Impetigo Medicines Price by Type (2018-2023) 4.3.2 Global Impetigo Medicines Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Impetigo Medicines Sales by Application 5.1.1 Global Impetigo Medicines Historical Sales by Application (2018-2023) 5.1.2 Global Impetigo Medicines Forecasted Sales by Application (2024-2029) 5.1.3 Global Impetigo Medicines Sales Market Share by Application (2018-2029) 5.2 Global Impetigo Medicines Revenue by Application 5.2.1 Global Impetigo Medicines Historical Revenue by Application (2018-2023) 5.2.2 Global Impetigo Medicines Forecasted Revenue by Application (2024-2029) 5.2.3 Global Impetigo Medicines Revenue Market Share by Application (2018-2029) 5.3 Global Impetigo Medicines Price by Application 5.3.1 Global Impetigo Medicines Price by Application (2018-2023) 5.3.2 Global Impetigo Medicines Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Impetigo Medicines Market Size by Type 6.1.1 US & Canada Impetigo Medicines Sales by Type (2018-2029) 6.1.2 US & Canada Impetigo Medicines Revenue by Type (2018-2029) 6.2 US & Canada Impetigo Medicines Market Size by Application 6.2.1 US & Canada Impetigo Medicines Sales by Application (2018-2029) 6.2.2 US & Canada Impetigo Medicines Revenue by Application (2018-2029) 6.3 US & Canada Impetigo Medicines Market Size by Country 6.3.1 US & Canada Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Impetigo Medicines Sales by Country (2018-2029) 6.3.3 US & Canada Impetigo Medicines Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Impetigo Medicines Market Size by Type 7.1.1 Europe Impetigo Medicines Sales by Type (2018-2029) 7.1.2 Europe Impetigo Medicines Revenue by Type (2018-2029) 7.2 Europe Impetigo Medicines Market Size by Application 7.2.1 Europe Impetigo Medicines Sales by Application (2018-2029) 7.2.2 Europe Impetigo Medicines Revenue by Application (2018-2029) 7.3 Europe Impetigo Medicines Market Size by Country 7.3.1 Europe Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Impetigo Medicines Sales by Country (2018-2029) 7.3.3 Europe Impetigo Medicines Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Impetigo Medicines Market Size 8.1.1 China Impetigo Medicines Sales (2018-2029) 8.1.2 China Impetigo Medicines Revenue (2018-2029) 8.2 China Impetigo Medicines Market Size by Application 8.2.1 China Impetigo Medicines Sales by Application (2018-2029) 8.2.2 China Impetigo Medicines Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Impetigo Medicines Market Size by Type 9.1.1 Asia Impetigo Medicines Sales by Type (2018-2029) 9.1.2 Asia Impetigo Medicines Revenue by Type (2018-2029) 9.2 Asia Impetigo Medicines Market Size by Application 9.2.1 Asia Impetigo Medicines Sales by Application (2018-2029) 9.2.2 Asia Impetigo Medicines Revenue by Application (2018-2029) 9.3 Asia Impetigo Medicines Sales by Region 9.3.1 Asia Impetigo Medicines Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Impetigo Medicines Revenue by Region (2018-2029) 9.3.3 Asia Impetigo Medicines Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Impetigo Medicines Market Size by Type 10.1.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Impetigo Medicines Market Size by Application 10.2.1 Middle East, Africa and Latin America Impetigo Medicines Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country 10.3.1 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Impetigo Medicines Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Impetigo Medicines Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Cutanea Life Sciences 11.1.1 Cutanea Life Sciences Company Information 11.1.2 Cutanea Life Sciences Overview 11.1.3 Cutanea Life Sciences Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 Cutanea Life Sciences Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Cutanea Life Sciences Recent Developments 11.2 LEO Pharma 11.2.1 LEO Pharma Company Information 11.2.2 LEO Pharma Overview 11.2.3 LEO Pharma Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 LEO Pharma Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 LEO Pharma Recent Developments 11.3 Medimetriks Pharmaceuticals 11.3.1 Medimetriks Pharmaceuticals Company Information 11.3.2 Medimetriks Pharmaceuticals Overview 11.3.3 Medimetriks Pharmaceuticals Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Medimetriks Pharmaceuticals Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Medimetriks Pharmaceuticals Recent Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Information 11.4.2 GlaxoSmithKline Overview 11.4.3 GlaxoSmithKline Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 GlaxoSmithKline Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 GlaxoSmithKline Recent Developments 11.5 Pfizer 11.5.1 Pfizer Company Information 11.5.2 Pfizer Overview 11.5.3 Pfizer Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Pfizer Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Pfizer Recent Developments 11.6 Karalex Pharma, LLC 11.6.1 Karalex Pharma, LLC Company Information 11.6.2 Karalex Pharma, LLC Overview 11.6.3 Karalex Pharma, LLC Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.6.4 Karalex Pharma, LLC Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Karalex Pharma, LLC Recent Developments 11.7 NovaBay Pharmaceuticals, Inc. 11.7.1 NovaBay Pharmaceuticals, Inc. Company Information 11.7.2 NovaBay Pharmaceuticals, Inc. Overview 11.7.3 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.7.4 NovaBay Pharmaceuticals, Inc. Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 NovaBay Pharmaceuticals, Inc. Recent Developments 11.8 Roche Holding AG 11.8.1 Roche Holding AG Company Information 11.8.2 Roche Holding AG Overview 11.8.3 Roche Holding AG Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.8.4 Roche Holding AG Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Roche Holding AG Recent Developments 11.9 SANDOZ GmbH 11.9.1 SANDOZ GmbH Company Information 11.9.2 SANDOZ GmbH Overview 11.9.3 SANDOZ GmbH Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.9.4 SANDOZ GmbH Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 SANDOZ GmbH Recent Developments 11.10 Taro Pharmaceutical Industries Ltd 11.10.1 Taro Pharmaceutical Industries Ltd Company Information 11.10.2 Taro Pharmaceutical Industries Ltd Overview 11.10.3 Taro Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.10.4 Taro Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Taro Pharmaceutical Industries Ltd Recent Developments 11.11 Teva Pharmaceutical Industries Ltd 11.11.1 Teva Pharmaceutical Industries Ltd Company Information 11.11.2 Teva Pharmaceutical Industries Ltd Overview 11.11.3 Teva Pharmaceutical Industries Ltd Impetigo Medicines Sales, Price, Revenue and Gross Margin (2018-2023) 11.11.4 Teva Pharmaceutical Industries Ltd Impetigo Medicines Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Teva Pharmaceutical Industries Ltd Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Impetigo Medicines Industry Chain Analysis 12.2 Impetigo Medicines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Impetigo Medicines Production Mode & Process 12.4 Impetigo Medicines Sales and Marketing 12.4.1 Impetigo Medicines Sales Channels 12.4.2 Impetigo Medicines Distributors 12.5 Impetigo Medicines Customers 13 Market Dynamics 13.1 Impetigo Medicines Industry Trends 13.2 Impetigo Medicines Market Drivers 13.3 Impetigo Medicines Market Challenges 13.4 Impetigo Medicines Market Restraints 14 Key Findings in The Global Impetigo Medicines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(調剤薬)の最新刊レポート
QYResearch 社の最新刊レポート本レポートと同じKEY WORD(medicines market)の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/04 10:27 147.72 円 163.39 円 196.69 円 |